Trevi Therapeutics TRVI
NASDAQ TRVI
$13.91 -0.27 (-1.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

Trevi Therapeutics (TRVI) Return on Assets [ROA] (2019 - 2026)

Updated

Trevi Therapeutics' Return on Assets [ROA] was -20.04% in Q2 2026, up 9.96 percentage points from -30.00% a year earlier and up 4.42 percentage points from the prior quarter.

Analysis

Trevi Therapeutics (TRVI) Return on Assets [ROA] (2019 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Trevi Therapeutics came in at -28.10%, up 19.74 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of +33.05 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -47.84% in FY2024 (-20.47 pp), -27.37% in FY2023 (+8.74 pp), -36.10% in FY2022 (+43.19 pp) and -79.29% in FY2021 (-18.14 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] in data going back to Q1 2019.
  • Compared with a year earlier, Return on Assets [ROA] has increased for five straight quarters, with an average year-over-year change of +7.58 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2022 (a gain of 73.68 percentage points); the worst was Q3 2021 (a drop of 40.91 percentage points).
  • Per Business Quant data, TRVI's Return on Assets [ROA] in the three quarters before Q2 2026 was -24.45% (Q1 2026), -21.77% (Q4 2025) and -22.50% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Trevi Therapeutics 1.98 Bn 1.98 Bn - -20.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.04%
Mar 31, 2026 -24.45%
Dec 31, 2025 -21.77%
Sep 30, 2025 -22.50%
Jun 30, 2025 -30.00%
Mar 31, 2025 -43.46%
Dec 31, 2024 -53.29%
Sep 30, 2024 -62.10%
Jun 30, 2024 -50.89%
Mar 31, 2024 -39.97%
Dec 31, 2023 -31.37%
Sep 30, 2023 -27.17%
Jun 30, 2023 -25.16%
Mar 31, 2023 -23.60%
Dec 31, 2022 -23.19%
Sep 30, 2022 -30.67%
Jun 30, 2022 -55.74%
Mar 31, 2022 -95.55%
Dec 31, 2021 -96.87%
Sep 30, 2021 -98.79%
API Access

Trevi Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=TRVI&period=max&api_key=YOUR_API_KEY